IMP 243

• Description :

  IMP 243 is a symmetric di-HSG (histamine-succinyl-glycine) bivalent hapten containing a Tscg-Cys ligand and two HSG groups. IMP 243 can be radiolabeled with 99mTc-pertechnetate. IMP 243 can be conjugated to other peptides to design bispecific antibodies (bsMAbs) for cancer research[1].

• UNSPSC :

  12352005

• Target :

  Biochemical Assay Reagents

• Type :

  Reference compound

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/imp-243.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(CCC(NCC(NCCCC[C@@H](C(N[C@@H](C(N[C@H](C(N[C@H](C(N)=O)CCCCNC([C@H](CS)NC(/C=N\NC(N)=S)=O)=O)=O)CCCCNC(CNC(CCC(NCCC1=CNC=N1)=O)=O)=O)=O)CC2=CC=C(O)C=C2)=O)NC(C)=O)=O)=O)NCCC3=CNC=N3

• Molecular Formula :

  C57H86N20O14S2

• Molecular Weight :

  1339.55

• References & Citations :

  [1]Sharkey RM, et al. A universal pretargeting system for cancer detection and therapy using bispecific antibody. Cancer Res. 2003 Jan 15;63 (2) :354-63.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [391267-29-1]